RxSight, Inc. Fair Value Adjustment of Warrants
RxSight, Inc. (RXST) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2023-03-06
- RxSight, Inc. fair value adjustment of warrants for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- RxSight, Inc. fair value adjustment of warrants for the quarter ending 2022-09-30 was $0.00.
- RxSight, Inc. fair value adjustment of warrants for the quarter ending 2022-06-30 was $0.00.
- RxSight, Inc. fair value adjustment of warrants for the quarter ending 2022-03-31 was $0.00.
- RxSight, Inc. fair value adjustment of warrants for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- RxSight, Inc. fair value adjustment of warrants for fiscal 2021 was $2.72M.
- RxSight, Inc. fair value adjustment of warrants for fiscal 2020 was -$63.01M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $0.00 derived: sum of 3 quarters · filed 2023-03-06 | $0.00 10-K · filed 2023-03-06 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | $5.43M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $5.43M derived: sum of 3 quarters · filed 2023-03-06 | $3.93M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2023-03-06 | $5.43M derived: sum of 2 quarters · filed 2023-03-06 | $3.93M derived: sum of 3 quarters · filed 2023-03-06 | $2.72M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-12-31 | $5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $3.93M derived: sum of 2 quarters · filed 2023-03-06 | $2.72M derived: sum of 3 quarters · filed 2023-03-06 | $2.72M 10-K · filed 2023-03-06 | -$2.72M 10-K · filed 2022-03-08 |
| 2021-09-30 | -$1.50M 10-Q · filed 2022-11-07 | -$2.72M derived: sum of 2 quarters · filed 2022-11-07 | -$2.72M 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | -$1.21M 10-Q · filed 2022-08-08 | -$1.21M 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | -$35.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$74.60M derived: sum of 2 quarters · filed 2022-03-08 | -$70.42M derived: sum of 3 quarters · filed 2022-03-08 | -$63.01M 10-K · filed 2022-03-08 | |
| 2020-09-30 | -$39.52M 10-Q · filed 2021-11-10 | -$35.34M derived: sum of 2 quarters · filed 2021-11-10 | -$27.93M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $4.18M 10-Q · filed 2021-09-09 | $11.59M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |